Drugs / calcium hydroxylapatite
calcium hydroxylapatite
Trials 5 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 12 trials | ||||||
| Phase 1 | NCT05885035 | Jan → Jun 2023 | cellulitis | Kalpna Kay Durairaj, MD, FACS | Completed | No outcome recorded |
| Phase 1 | NCT04176068 | Apr 2019 → Dec 2021 | cutis laxa | University of California, Irvine | Completed | No outcome recorded |
| Phase 42 trials | ||||||
| Phase 4 | NCT05039723 | Sep 2021 → Mar 2022 | — | Main Line Center for Laser Surgery | Completed | No outcome recorded |
| Phase 4 | NCT01225354 | Aug 2010 → Aug 2011 | — | DeNova Research | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT07028567 | Jan → Jun 2023 | skin atrophy | Tanta University | Completed | No outcome recorded |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | calcium hydroxylapatite | “Calcium hydroxylapatite filler (CaHA; Radiesse) is a synthetic, non-animal derived product composed of minerals that occur naturally in bone and teeth.” PMID 24301235 ↗ Dec 2013 |
| Known as | CaHA | “Calcium hydroxylapatite filler (CaHA; Radiesse) is a synthetic, non-animal derived product composed of minerals that occur naturally in bone and teeth.” PMID 24301235 ↗ Dec 20131“Patients received calcium hydroxylapatite filler (CaHA) (Radiesse®).” NCT07028567 ↗ |
| Known as | calcium hydroxyapatite | “combination, global facial and/or neck treatment with IncobotulinumA (Xeomin), HA (Belotero) and/or calcium hydroxyapatite (Radiesse+, Radiesse Classic).” NCT05039723 ↗ |
| Known as | Radiesse | “Calcium hydroxylapatite filler (CaHA; Radiesse) is a synthetic, non-animal derived product composed of minerals that occur naturally in bone and teeth.” PMID 24301235 ↗ Dec 20132“Patients received calcium hydroxylapatite filler (CaHA) (Radiesse®).” NCT07028567 ↗ “calcium hydroxylapatite (Radiesse) and IFUS (Ulthera)” NCT04176068 ↗ |
| Known as | Radiesse Classic | “calcium hydroxyapatite (Radiesse+, Radiesse Classic)” NCT05039723 ↗ |
| Modality | Other / unclassified | “Calcium hydroxylapatite filler (CaHA; Radiesse) is a synthetic, non-animal derived product composed of minerals that occur naturally in bone and teeth.” PMID 24301235 ↗ Dec 2013 |
| Route | Other | “Subjects will be treated with subdermal injections of CaHA diluted 1:1 with normal saline solution and 1% Lidocaine” NCT05885035 ↗ |